降脂益肝汤预处理脂肪间充质干细胞来源外泌体对MAFLD铁死亡的保护作用OA
Protective effects of exosomes from adipose-derived mesenchymal stem cells preconditioned with Jiangzhi Yigan Decoction against ferroptosis in metabolic dysfunction-associated fatty liver disease
目的 探讨降脂益肝汤预处理的人脂肪间充质干细胞来源外泌体(JZYGT-Exo)对代谢相关脂肪性肝病(MAFLD)细胞模型铁死亡的影响及其潜在机制.方法 采用降脂益肝汤含药血清干预人脂肪间充质干细胞并提取外泌体,通过透射电子显微镜(TEM)及纳米颗粒跟踪分析进行鉴定.采用油酸(OA)和棕榈酸(PA)混合诱导HepG2细胞建立MAFLD体外模型.实验设置模型组、JZYGT-Exo组、JZYGT-Exo+Erastin组及JZYGT-Exo+Fer-1组.通过油红O染色、细胞内甘油三酯(TG)及葡萄糖含量检测评估脂质代谢;采用CCK-8法检测细胞存活率,检测超氧化物歧化酶(SOD)、丙二醛(MDA)、活性氧(ROS)、过氧化氢酶(CAT)及谷胱甘肽过氧化物酶(GSH-Px)水平;JC-1及Mito-Tracker探针评估线粒体膜电位与形态;TEM观察线粒体超微结构以及蛋白免疫印迹法检测GPX4、Nrf2蛋白表达.结果 成功提取并鉴定出JZYGT-Exo,其可被MAFLD模型细胞有效摄取.JZYGT-Exo干预可显著减少细胞内脂质沉积,降低TG及葡萄糖水平(P<0.01,P<0.001).细胞死亡方式筛选结果表明,JZYGT-Exo可特异性拮抗爱拉斯汀诱导的铁死亡.在铁死亡相关指标中,JZYGT-Exo 可提高 SOD、CAT、GSH-Px 活性(P<0.05),降低 MDA 与 ROS 水平(P<0.05,P<0.01),提升线粒体膜电位(P<0.05),改善线粒体形态与超微结构,减少线粒体铁沉积,并上调GPX4与Nrf2蛋白表达(P<0.01).上述效应可被爱拉斯汀部分逆转,并被Fer-1进一步协同增强.结论 降脂益肝汤预处理的脂肪间充质干细胞外泌体可通过调节氧化应激与铁死亡关键蛋白表达,改善MAFLD模型细胞的脂质代谢紊乱并抑制铁死亡,其作用机制可能与激活Nrf2/GPX4信号通路有关.
Objective To investigate the effect of exosomes derived from human adipose-derived mesenchymal stem cells preconditioned with Jiangzhi Yigan Decoction(JZYGT-Exo)on ferroptosis in a metabolic dysfunction-associated fatty liver disease(MAFLD)cell model and the underlying mechanisms involved.Methods Human adipose-derived mesenchymal stem cells were treated with serum containing JZYGT to obtain JZYGT-Exo,which were characterized using transmission electron microscopy(TEM)and nanoparticle tracking.An in vitro MAFLD model was established by inducing human hepatoblastoma HepG2 cells with a mixture of oleic acid and palmitic acid.Model,JZYGT-Exo,JZYGT-Exo+Era group,and JZYGT-Exo+Fer-1 groups were created.Lipid metabolism was assessed by Oil Red O staining,and intracellular triglyceride(TG)and glucose levels were measured.The cell viability was detected by the CCK-8 method.Levels of superoxide dismutase(SOD),malondialdehyde(MDA),reactive oxygen species(ROS),catalase(CAT),and glutathione peroxidase(GSH-Px)were detected.Mitochondrial membrane potential and morphology were evaluated using JC-1 and Mito-Tracker probes,respectively.Mitochondrial ultrastructure was observed by TEM,and glutathione peroxidase 4(GPX4)and nuclear factor erythroid 2-related factor 2(Nrf2)protein expression were detected by Western blot analysis.Results JZYGT-Exo were isolated and identified,and were effectively taken up by MAFLD model cells.JZYGT-Exo intervention significantly reduced intracellular lipid deposition as well as TG and glucose levels(P<0.01,P<0.001).Cell death mode screening indicated that JZYGT-Exo antagonized Erastin-induced ferroptosis.JZYGT-Exo increased SOD,CAT,and GSH-Px activities(P<0.05),decreased MDA and ROS levels(P<0.05,P<0.01),enhanced mitochondrial membrane potential(P<0.05),improved mitochondrial morphology and ultrastructure,reduced mitochondrial iron deposition,and up-regulated GPX4 and Nrf2 protein expression(P<0.01);these effects were partially reversed by Erastin and were enhanced by Fer-1.Conclusions JZYGT-Exo ameliorated lipid metabolism disorders and inhibited ferroptosis in MAFLD model cells by regulating key oxidative stress and ferroptosis proteins.Their mechanism of action may be related to Nrf2/GPX4 signaling activation.
彭建军;邓芳
湖南省张家界慈利县中医医院脾胃病科,湖南张家界 427200湖南省中西医结合医院(湖南省中医药研究院附属医院)消化内科,长沙 410006
医药卫生
降脂益肝汤脂肪间充干细胞外泌体代谢相关脂肪性肝病铁死亡
Jiangzhi Yigan Decoctionadipose-derived mesenchymal stem cellsexosomesmetabolic dysfunction-associated fatty liver diseaseferroptosis
《中国比较医学杂志》 2026 (15)
50-63,14
湖南省自然科学基金(2025JJ50741).
评论